Abstract

Intracellular calcium ion content is tightly regulated for the maintenance of cellular functions and cell survival. Calbindin-D9k (CaBP-9k) is responsible for regulating the distribution of cytosolic free-calcium ions. In this study, we aimed to investigate the effect of CaBP-9k on cell survival in pancreatic beta cells. Six-month-old wildtype CaBP-9k, CaBP-28k, and CaBP-9k/28k knockout (KO) mice were used to compare the pathological phenotypes of calcium-binding protein-deleted mice. Subsequently, the endoplasmic reticulum (ER) stress reducer tauroursodeoxycholic acid (TUDCA) was administered to wildtype and CaBP-9k KO mice. In vitro assessment of the role of CaBP-9k was performed following CaBP-9k overexpression and treatment with the ER stress inducer thapsigargin. Six-month-old CaBP-9k KO mice showed reduced islet volume and up-regulation of cell death markers resulting from ER stress, which led to pancreatic beta cell death. TUDCA treatment recovered islet volume, serum insulin level, and abdominal fat storage by CaBP-9k ablation. CaBP-9k overexpression elevated insulin secretion and recovered thapsigargin-induced ER stress in the INS-1E cell line. The results of this study show that CaBP-9k can protect pancreatic beta cell survival from ER stress and contribute to glucose homeostasis, which can reduce the risk of type 1 diabetes and provide the molecular basis for calcium supplementation to diabetic patients.

Highlights

  • Calbindin-D9k (CaBP-9k) is a 9-kDa polypeptide containing two EF-calcium-binding sites, which are usually expressed in the intestine, kidney, uterus, and pituitary gland

  • Intracellular free calcium ion and endoplasmic reticulum (ER) calcium ion levels are modulated by several calcium channels, including the sarcoplasmic reticulum calcium ion ATPase (SERCA) 2a and 2b, inositol 1,4,5-trisphosphate receptor (IP3R), and ryanodine receptor 2 (RyR2)

  • The insulin level was reduced (Figure 1E), and urinary glucose (Figure 1F) and water consumption (Figure 1G) were elevated, to diabetic symptoms in CaBP-9k-deleted compared to WT mice

Read more

Summary

Introduction

Calbindin-D9k (CaBP-9k) is a 9-kDa polypeptide containing two EF-calcium-binding sites, which are usually expressed in the intestine, kidney, uterus, and pituitary gland. CaBP-9k regulates the amount of intracellular calcium in order to prevent cell death caused by toxic free calcium levels [2]. The intracellular calcium ion concentration is regulated via the endoplasmic reticulum (ER)-mediated pathway, in which calcium ions move across the ER membrane via calcium channels and pumps [3]. Intracellular free calcium ion and ER calcium ion levels are modulated by several calcium channels, including the sarcoplasmic reticulum calcium ion ATPase (SERCA) 2a and 2b, inositol 1,4,5-trisphosphate receptor (IP3R), and ryanodine receptor 2 (RyR2). Disruption of intracellular calcium ion homeostasis can trigger ER stress [5]. Dysregulation of the intracellular calcium ion level can result in the activation of apoptotic pathways [8,9]

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.